Geneva, Feb. 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119095) titled 'A Randomized Controlled Trial of Idebenone for Cognitive Impairment in Cerebral Small Vessel Disease' on Feb. 14.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Qilu Hospital of Shandong University
Condition:
Cerebral small vessel disease
Intervention:
Drug Group:Edaravone 30mg, three times daily, oral
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-01
Target Sample Size: Drug Group:79;Control Group:79;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=308216
Disclaimer: Curated by HT Syndic...